Research & Reviews: A Journal of Medicine

ISSN: 2249-8648

Editors Overview

rrjom maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

Artificial Intelligence in Ophthalmology

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Artificial Intelligence (AI) is poised to play a major part in pharmaceutical and wellbeing care within the predictable future as a tool to help in the screening, conclusion, and administration of different diseases. Ophthalmology is one of the driving specialties within the field of AI and ophthalmology produces an enormous volume of imaging and information that may be utilized to prepare and approve AI. The reason for AI is to form computers, imitate the way of thinking, and improve our work productivity in the modern fast-paced life. It has ended up one of the foremost influential information technology revolutions. The application of AI in ophthalmology concentrates on illnesses with a high rate, such as diabetic retinopathy, age-related macular degeneration, glaucoma, retinopathy of rashness, age-related or innate cataract, and a few with retinal vein impediments. AI is broadly acknowledged as the appearance of numerous robots in contrast areas, particularly in bioinformatics. Combined with pharmaceuticals, a few robot-assisted surgeries have been conducted effectively. It makes doctors work more accurately and successfully. These days, AI-assisted restorative screening and determination based on pictures are developing. In the field of ophthalmology, particularly within the blind-causing illnesses, it is basically to medical imaging recognizable proof and assistant diagnosis. The application of this innovation of AI primarily depends on machine learning, which is spoken to by numerical calculations and models shaped through parts of input encounters.


Artificial Intelligence (AI), Ophthalmology, Imaging, Retinopathy, Computers, Information

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals:






950 $